Sunday, November 17, 2024
- Advertisement -spot_img

TAG

Northwest Biotherapeutics

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

Complementary to Technology & IP Already Owned or In-Licensed;Significant Step in Building a Leading Dendritic Cell Franchise BETHESDA, Md., June 17, 2024 /PRNewswire/ --...

Latest news

- Advertisement -spot_img